Huntington's Disease

Huntington's disease (HD) results from genetically programmed degeneration of brain cells, called neurons, in certain areas of the brain. This degeneration causes uncontrolled movements, loss of intellectual faculties, and emotional disturbance. HD is a familial disease, passed from parent to child through a mutation in the normal gene. Each child of an HD parent has a 50-50 chance of inheriting the HD gene. If a child does not inherit the HD gene, he or she will not develop the disease and cannot pass it to subsequent generations. A person who inherits the HD gene will sooner or later develop the disease. Whether one child inherits the gene has no bearing on whether others will or will not inherit the gene. Some early symptoms of HD are mood swings, depression, irritability or trouble driving, learning new things, remembering a fact, or making a decision. As the disease progresses, concentration on intellectual tasks becomes increasingly difficult and the patient may have difficulty feeding himself or herself and swallowing. The rate of disease progression and the age of onset vary from person to person. A genetic test, coupled with a complete medical history and neurological and laboratory tests, helps physicians diagnose HD. Presymptomic testing is available for individuals who are at risk for carrying the HD gene. In 1 to 3 percent of individuals with HD, no family history of HD can be found.
What is Huntington's Disease?

Huntington’s disease is an incurable neurodegenerative disease that affects muscle coordination and cognitive function. Symptoms of the disease usually start to develop around middle age. Huntington’s disease used to be called Huntington’s chorea because it is the most commonly inherited condition to lead to the involuntary movements referred to as chorea.

Read More

Overview

Feature Articles

Latest Huntington's Disease News and Research

New insights into early Huntington's disease mechanisms

New insights into early Huntington's disease mechanisms

Researchers develop the first polymer-based therapeutic for Huntington’s disease

Researchers develop the first polymer-based therapeutic for Huntington’s disease

Huntington’s disease symptoms reduced by new peptide-polymer therapy

Huntington’s disease symptoms reduced by new peptide-polymer therapy

Researchers discover key biochemical mechanism in Huntington's disease development

Researchers discover key biochemical mechanism in Huntington's disease development

Genetics and childhood attention problems linked to psychotic-like experiences in youth

Genetics and childhood attention problems linked to psychotic-like experiences in youth

Research heralds in a new era for genetic sequencing and testing

Research heralds in a new era for genetic sequencing and testing

Defective DNA repair mechanism linked to Huntington's disease progression

Defective DNA repair mechanism linked to Huntington's disease progression

New insights into the mechanism of autophagy activation

New insights into the mechanism of autophagy activation

Scientists identify new trigger for autophagy

Scientists identify new trigger for autophagy

Study uncovers mechanisms behind Fuchs Endothelial Corneal Dystrophy

Study uncovers mechanisms behind Fuchs Endothelial Corneal Dystrophy

Scientists develop selective therapy for tau tangles

Scientists develop selective therapy for tau tangles

How can microdialysis benefit drug development?

How can microdialysis benefit drug development?

Cholesterol imbalance linked to neurodegeneration, study suggests potential strategies for intervention

Cholesterol imbalance linked to neurodegeneration, study suggests potential strategies for intervention

New lab technique captures aging effects in Alzheimer's disease development

New lab technique captures aging effects in Alzheimer's disease development

UCLA research highlights delayed Huntington's disease diagnosis for Black patients

UCLA research highlights delayed Huntington's disease diagnosis for Black patients

WEHI spinout aims to revolutionize the development of cancer drugs

WEHI spinout aims to revolutionize the development of cancer drugs

Vascular changes in pre-symptomatic stages of Huntington's disease offer new predictive potential

Vascular changes in pre-symptomatic stages of Huntington's disease offer new predictive potential

Boosting mitochondrial health can reverse protein clumping in aging and Alzheimer's

Boosting mitochondrial health can reverse protein clumping in aging and Alzheimer's

Novel gene-delivery vehicle shows promise for treating brain disorders

Novel gene-delivery vehicle shows promise for treating brain disorders

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.